Shivom Investment to Approve Pending Financial Results on September 12, 2026

OTHER
Whalesbook Corporate News Logo
AuthorAnanya Iyer|Published at:
Shivom Investment to Approve Pending Financial Results on September 12, 2026

Shivom Investment & Consultancy Ltd has scheduled a board meeting for September 12, 2026, to approve audited Q4 FY25 and unaudited Q1 FY26 financial results. This meeting aims to resolve reporting delays caused by the company's previous Corporate Insolvency Resolution Process (CIRP) and restore regulatory compliance.

Shivom Investment & Consultancy Board Meeting Update

Financial Results: Audited Q4 FY25 and Unaudited Q1 FY26

Reader Takeaway: Normalizing financial disclosures is a critical step to restoring transparency for investors post-insolvency.

What just happened

Shivom Investment & Consultancy Ltd has notified the BSE that its Board of Directors will convene on September 12, 2026. The primary objective of this session is to review, discuss, and approve pending financial statements that could not be filed during the company’s Corporate Insolvency Resolution Process (CIRP).

Why this matters

The meeting addresses a critical compliance backlog. During the insolvency process, the company was unable to adhere to standard reporting timelines. By approving these results, the company is taking a formal step to clear legacy regulatory hurdles and provide shareholders with an accurate view of its financial health.

What to expect

Investors will gain visibility into the company's performance for the quarter and year ended March 31, 2025 (audited), as well as the quarter ended June 30, 2025 (unaudited). These documents will serve as the baseline for assessing the company’s current financial status following the conclusion of its CIRP.

What to track next

Shareholders should monitor the post-meeting filings for the official release of these financial statements. This will provide the first clear insight into the company’s post-insolvency financial structure and operational viability.

Disclaimer: This article is published for informational purposes only. This is not a buy sell recommendation.